Genetically engineered live attenuated influenza A virus vaccine candidates
about
Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic VirusEngineering temperature sensitive live attenuated influenza vaccines from emerging viruses.Influenza vaccines: present and future.Traditional and new influenza vaccinesHemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses.
P2860
Genetically engineered live attenuated influenza A virus vaccine candidates
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Genetically engineered live attenuated influenza A virus vaccine candidates
@ast
Genetically engineered live attenuated influenza A virus vaccine candidates
@en
type
label
Genetically engineered live attenuated influenza A virus vaccine candidates
@ast
Genetically engineered live attenuated influenza A virus vaccine candidates
@en
prefLabel
Genetically engineered live attenuated influenza A virus vaccine candidates
@ast
Genetically engineered live attenuated influenza A virus vaccine candidates
@en
P2093
P2860
P1433
P1476
Genetically engineered live attenuated influenza A virus vaccine candidates
@en
P2093
P2860
P304
P407
P577
1997-04-01T00:00:00Z